Regulation of P-glycoprotein efflux activity by Z-guggulsterone of Commiphora mukul at the blood-brain barrier

被引:4
作者
Xu, Hong-Bin [1 ]
Yu, Jing
Xu, Lu-Zhong
Fu, Jun
机构
[1] Tongji Univ, Sch Med, Dept Pharm, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China
关键词
Z-guggulsterone; P-glycoprotein ATPase; Multidrug resistance-associated protein 1; Rhodamine; 123; MEDIATED MULTIDRUG-RESISTANCE; PENETRATION; EXPRESSION; REVERSAL; PROTEIN; INHIBITION; TRANSPORT; ATPASE;
D O I
10.1016/j.jns.2016.02.046
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The present study was to investigate whether Z-guggulsterone had the regulatory effect on the activity and expression of P-glycoprotein in rat brain microvessel endothelial cells (rBMECs) and in rat brain. Inorganic phosphate liberation assay, high performance liquid chromatography, and western blot analysis were performed to assess the P-glycoprotein ATPase activity, the accumulation of NaF and rhodamine 123, and P-glycoprotein and MRP1 expression. The results showed that Z-guggulsterone (0-100 mu M) significantly enhanced basal P-glycoprotein ATPase activity in a concentration-dependent manner. Tetrandrine (0.1, 0.3,1 mu M) or cyclosporine A (0.1, 0.3, 1 mu M) had non-competitively inhibitory manner on Z-guggulsterone-stimulated P-glycoprotein ATPase activity, suggesting that Z-guggulsterone might have unique binding site or regulating site on P-glycoprotein. However, Z-guggulsterone (30, 100 mu M) had almost no influence on MRP1 expression in rBMECs. Further results revealed that Z-guggulsterone (50 mg/kg) significantly increased the accumulation of rhodamine 123 by down-regulating P-glycoprotein expression in rat brain, as compared with control (P < 0.05). Our studies suggested that Z-guggulsterone potentially inhibited the activity and expression of P-glycoprotein in rBMECs and in rat brain. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
  • [21] Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine
    Namanja-Magliano, Hilda A.
    Bohn, Kelsey
    Agrawal, Neha
    Willoughby, Meghan E.
    Hrycyna, Christine A.
    Chmielewski, Jean
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (19) : 5128 - 5132
  • [22] Guggulsterone of Commiphora mukul resin reverses drug resistance in imatinib-resistant leukemic cells by inhibiting cyclooxygenase-2 and P-glycoprotein
    Xu, Hong-Bin
    Xu, Lu-Zhong
    Mao, Xia-Ping
    Fu, Jun
    PHYTOMEDICINE, 2014, 21 (07) : 1004 - 1009
  • [23] Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine Administration
    Zhao, Rong
    Kalvass, J. Cory
    Yanni, Souzan B.
    Bridges, Arlene S.
    Pollack, Gary M.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) : 529 - 535
  • [24] Liposomes Coloaded with Elacridar and Tariquidar To Modulate the P-Glycoprotein at the Blood-Brain Barrier
    Montesinos, Rita Nieto
    Beduneau, Arnaud
    Lamprecht, Alf
    Pellequer, Yann
    MOLECULAR PHARMACEUTICS, 2015, 12 (11) : 3829 - 3838
  • [25] Assessing the Impact of Lithium Chloride on the Expression of P-Glycoprotein at the Blood-Brain Barrier
    Newman, Stephanie A.
    Pan, Yijun
    Short, Jennifer L.
    Nicolazzo, Joseph A.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2625 - 2631
  • [26] TGF-β1 Regulation of Multidrug Resistance P-glycoprotein in the Developing Male Blood-Brain Barrier
    Baello, Stephanie
    Iqbal, Majid
    Bloise, Enrrico
    Javam, Mohsen
    Gibb, William
    Matthews, Stephen G.
    ENDOCRINOLOGY, 2014, 155 (02) : 475 - 484
  • [27] Exploratory Study of Sex Differences in P-Glycoprotein Function at the Blood-Brain Barrier
    de Souza, Giordana Salvi
    Liu, Wanling
    Mossel, Pascalle
    Somsen, Joost F.
    Bartels, Anna L.
    Furini, Cristiane R. G.
    Lammertsma, Adriaan A.
    Tsoumpas, Charalampos
    Luurtsema, Gert
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (04):
  • [28] Inhibitory Effects of Furanocoumarin Derivatives in Kampo Extract Medicines on P-Glycoprotein at the Blood-Brain Barrier
    Iwanaga, Kazunori
    Yoneda, Shinji
    Hamahata, Yukimi
    Miyazaki, Makoto
    Shibano, Makio
    Taniguchi, Masahiko
    Baba, Kimiye
    Kakemi, Masawo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (08) : 1246 - 1251
  • [29] Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function
    Goutal, Sebastien
    Novell, Anthony
    Leterrier, Sarah
    Breuil, Louise
    Selingue, Erwan
    Gerstenmayer, Matthieu
    Marie, Solene
    Saubamea, Bruno
    Caille, Fabien
    Langer, Oliver
    Truillet, Charles
    Larrat, Benoit
    Tournier, Nicolas
    JOURNAL OF CONTROLLED RELEASE, 2023, 361 : 483 - 492
  • [30] P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier
    Decaix, Theodore
    Vrillon, Agathe
    Paquet, Claire
    Laprevote, Olivier
    Lilamand, Matthieu
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DU VIEILLISSEMENT, 2024, 22 (02) : 137 - 144